Cynthia Butitta
Patrimonio netto: 1 M $ in data 31/08/2026
Patrimonio netto: 1 M $ in data 31/08/2026
Ms. Cynthia M.
Butitta is an Independent Director at Olema Pharmaceuticals, Inc., an Independent Director at Autolus Ltd., an Independent Non-Executive Director at Autolus Therapeutics Plc, an Independent Director at UroGen Pharma Ltd. and a Founder at Butitta Consulting Services LLC.
She is on the Board of Directors at Olema Pharmaceuticals, Inc., Autolus Ltd., Autolus Therapeutics Plc and UroGen Pharma Ltd. Ms. Butitta was previously employed as an Independent Director by Century Therapeutics, Inc., a Chief Operating Officer by Kite Pharma, Inc., a Chief Financial Officer & Senior Vice President by NextWave Pharmaceuticals, Inc., a Chief Operating & Financial Officer by Telik, Inc., a Partner by Altair Capital Associates LLC, a CFO, VP-Finance & Administration by Connective Therapeutics, Inc., and a Chief Financial Officer & VP-Administration by InSite Vision, Inc. She also served on the board at Century Therapeutics, Inc. /Old/ and Catalyst Semiconductor, Inc. She received her undergraduate degree from Edgewood College and an MBA from the University of Wisconsin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/06/2026 | 83.876 ( 0,1% ) | 874 827 $ | 31/08/2026 | |
| 12/06/2025 | 98.936 ( 0,05% ) | 202 819 $ | 31/08/2026 | |
| 22/06/2026 | 2.000 ( 0% ) | 86 180 $ | 31/08/2026 | |
| 29/06/2026 | 10.000 ( 0% ) | 23 500 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| UROGEN PHARMA LTD. | Direttore/Membro del Consiglio | 01/10/2017 |
| AUTOLUS THERAPEUTICS PLC | Direttore/Membro del Consiglio | 01/03/2018 |
| OLEMA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/08/2020 |
Butitta Consulting Services LLC | Fondatore | 13/11/2009 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Direttore/Membro del Consiglio | 15/03/2018 |
| Società | Posizione | Fine |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 14/08/2025 |
| KITE PHARMA INC | Direttore Finanziario/CFO | 16/05/2016 |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Direttore Finanziario/CFO | 01/12/2012 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Direttore Finanziario/CFO | 01/12/2010 |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
InSite Vision, Inc.
InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Catalyst Semiconductor, Inc.
Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Provides semiconductor products | Electronic Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Edgewood College
Edgewood College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Butitta Consulting Services LLC | |
Altair Capital Associates LLC | |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UroGen Pharma Ltd.
UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Century Therapeutics, Inc.
Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale